Latest AI and machine learning research in atopy for healthcare professionals.
Asthma caused around 436,000 deaths globally in 2021. Predicting asthma attacks can save lives, redu...
BACKGROUND: The aim of this study is to compare the performance of three large language models (Chat...
BACKGROUND: Mitochondrial dysfunction and neuroinflammation are critically implicated in the pathoge...
Asthma exhibits significant clinical heterogeneity, necessitating precise phenotyping for personaliz...
Severe asthma remains a major unmet clinical challenge due to its marked immunological heterogeneity...
To assess the feasibility of an electronic nose (e-nose) for volatile organic compounds (VOCs) to cl...
Asthma and Chronic Obstructive Pulmonary Disease (COPD) are among the most prevalent chronic respira...
Chronic respiratory diseases represent a leading cause of global mortality, yet robust prediction to...
BACKGROUND: Atopic dermatitis (AD) is a prevalent inflammatory skin disease and a major source of di...
BACKGROUND: Asthma is a common chronic inflammatory airway disease. Accumulating evidence highlights...
BACKGROUND: Sepsis-induced acute respiratory distress syndrome (ARDS) is a life-threatening form of ...
Childhood allergic asthma (CAA) is a chronic airway inflammatory disorder driven by allergens, and i...
BACKGROUND: Osteoarthritis (OA) is a chronic degenerative joint disease characterized by the progres...
Asthma is a chronic inflammatory airway disease characterized by barrier dysfunction and excessive i...
Artificial intelligence (AI) in dermatology has moved beyond the early paradigm of single-image clas...
PURPOSE OF REVIEW: The review examines the application of machine learning (ML) and large language m...
BACKGROUND: Artificial intelligence (AI) is emerging as a critical tool for nurse practitioners deli...
OBJECTIVE: Exposure to benzo(a)pyrene (BaP) negatively affects lung inflammation in patients with as...
Generative artificial intelligence (AI) is rapidly emerging as a valuable tool in medicine, with inc...
BACKGROUND: Limited therapeutic options are available for patients with advanced-stage mycosis fungo...
BACKGROUND: Equitable access to prescribed therapies remains challenging for older adults with chron...